Takashi Saotome

Matsudo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Survival benefit of HER2-targeted or androgen deprivation therapy in salivary duct carcinoma.

Survival benefit of HER2-targeted or androgen deprivation therapy in salivary duct carcinoma.

Journal: Therapeutic advances in medical oncology

Published: March 23, 2022

Nivolumab-induced Myositis and Myocarditis with Positive Anti-titin Antibody and Anti-voltage-gated Potassium Channel Kv1.4 Antibody.

Nivolumab-induced Myositis and Myocarditis with Positive Anti-titin Antibody and Anti-voltage-gated Potassium Channel Kv1.4 Antibody.

Journal: Internal medicine (Tokyo, Japan)

Published: March 22, 2022

Initial Safety Analysis of CapeOx for Elderly Patients With Advanced Gastric Cancer Patients: A Phase II Trial.

Initial Safety Analysis of CapeOx for Elderly Patients With Advanced Gastric Cancer Patients: A Phase II Trial.

Journal: Anticancer research

Published: March 06, 2022

Predictive and Prognostic Biomarker Identification in a Large Cohort of Androgen Receptor-Positive Salivary Duct Carcinoma Patients Scheduled for Combined Androgen Blockade.

Predictive and Prognostic Biomarker Identification in a Large Cohort of Androgen Receptor-Positive Salivary Duct Carcinoma Patients Scheduled for Combined Androgen Blockade.

Journal: Cancers

Published: June 19, 2021

Multicentre, retrospective study of the efficacy and safety of nivolumab for recurrent and metastatic salivary gland carcinoma.

Multicentre, retrospective study of the efficacy and safety of nivolumab for recurrent and metastatic salivary gland carcinoma.

Journal: Scientific reports

Published: June 08, 2020

Carboplatin and Docetaxel in Patients With Salivary Gland Carcinoma: A Retrospective Study.

Carboplatin and Docetaxel in Patients With Salivary Gland Carcinoma: A Retrospective Study.

Journal: In vivo (Athens, Greece)

Published: February 05, 2019

Phase II Trial of Trastuzumab and Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2-Positive Salivary Duct Carcinoma.

Phase II Trial of Trastuzumab and Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2-Positive Salivary Duct Carcinoma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: November 20, 2018

A prospective phase II study of combined androgen blockade in patients with androgen receptor-positive metastatic or locally advanced unresectable salivary gland carcinoma.

A prospective phase II study of combined androgen blockade in patients with androgen receptor-positive metastatic or locally advanced unresectable salivary gland carcinoma.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: December 07, 2017

Metastasis of Mammary Gland Malignant Phyllodes Tumor to the Mandibular Region: A Case Report and Review of the Literature.

Metastasis of Mammary Gland Malignant Phyllodes Tumor to the Mandibular Region: A Case Report and Review of the Literature.

Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons

Published: June 12, 2016

A Case of a Metastatic Liver Tumor from a Thymic Carcinoma Detected During a Cesarean Section

A Case of a Metastatic Liver Tumor from a Thymic Carcinoma Detected During a Cesarean Section

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: January 26, 2016

Chemotherapy for anaplastic thyroid cancer using docetaxel and cisplatin: report of eight cases.

Chemotherapy for anaplastic thyroid cancer using docetaxel and cisplatin: report of eight cases.

Journal: Surgery today

Published: March 04, 2015

Chemotherapy for anaplastic thyroid cancer using docetaxel and cisplatin: report of eight cases.

Chemotherapy for anaplastic thyroid cancer using docetaxel and cisplatin: report of eight cases.

Journal: Surgery today

Published: April 23, 2013

Showing 1-12 of 13

Last Updated: 09/26/2026